| Identification | Back Directory | [Name]
N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide | [CAS]
1135243-19-4 | [Synonyms]
ML012
VU 0255035
CID24768606
VU0255035 hydrate
N-{3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl}-2,1,3-benz...
N-[3-Oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide
2,1,3-Benzothiadiazole-4-sulfonamide, N-[3-oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-
N-(3-Oxo-3-(4-(pyridin-4-yl)piperazin-1-yl)propyl)benzo[c][1,2,5]thiadiazole-4-sulfonaMide
N-[3-oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide hydrate
N-(3-oxo-3-(4-(pyridine-4-yl)piperazin-1-yl)propyl)benzo[c][1,2,5]thiadiazole-4-sulfonamide hydrate | [Molecular Formula]
C18H20N6O3S2 | [MDL Number]
MFCD16875440 | [MOL File]
1135243-19-4.mol | [Molecular Weight]
432.52 |
| Chemical Properties | Back Directory | [Melting point ]
159.7-160.2 °C(Solv: dichloromethane (75-09-2); hexane (110-54-3)) | [Boiling point ]
689.3±65.0 °C(Predicted) | [density ]
1.447±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: >5mg/mL | [form ]
powder | [pka]
8.97±0.50(Predicted) | [color ]
yellow |
| Hazard Information | Back Directory | [Uses]
VU 0255035 is a novel, selective antagonist of M1 mAChRs, which has potential treatment in CNS disorders. | [Definition]
ChEBI: N-[3-oxo-3-(4-pyridin-4-yl-1-piperazinyl)propyl]-2,1,3-benzothiadiazole-4-sulfonamide is a member of pyridines and a member of piperazines. | [storage]
Store at -20°C |
|
| Company Name: |
BePharm Ltd
|
| Tel: |
400-685-9117 |
| Website: |
www.bepharm.com |
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|